Cargando…
RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit
The 90 kDa Ribosomal S6 Kinase (RSK) drives cell proliferation and survival in cancers, although its oncogenic mechanism has not been well characterized. Phosphorylated level of RSK (T573) was increased in acute myeloid leukemia (AML) patients and associated with poor survival. To examine the role o...
Autores principales: | Chae, Hee-Don, Dutta, Ritika, Tiu, Bruce, Hoff, Fieke W., Accordi, Benedetta, Serafin, Valentina, Youn, Minyoung, Huang, Min, Sumarsono, Nathan, Davis, Kara L., Lacayo, Norman J., Pigazzi, Martina, Horton, Terzah M., Kornblau, Steven M., Sakamoto, Kathleen M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7321696/ https://www.ncbi.nlm.nih.gov/pubmed/32637030 http://dx.doi.org/10.18632/oncotarget.27630 |
Ejemplares similares
-
A combination of SILAC and nucleotide acyl phosphate labelling reveals unexpected targets of the Rsk inhibitor BI-D1870
por: Edgar, Alexander J., et al.
Publicado: (2014) -
AML-343: Loss of H3K27 Methylation Identifies Poor Outcomes in Adult-Onset Acute Lymphoblastic and Myeloid Leukemia
por: Dijk, Anneke van, et al.
Publicado: (2020) -
DNA Damage Response−Related Proteins Are Prognostic for Outcome in Both Adult and Pediatric Acute Myelogenous Leukemia Patients: Samples from Adults and from Children Enrolled in a Children’s Oncology Group Study
por: Hubner, Stefan E., et al.
Publicado: (2023) -
The p90 ribosomal S6 kinase (RSK) inhibitor BI-D1870 prevents gamma irradiation-induced apoptosis and mediates senescence via RSK- and p53-independent accumulation of p21(WAF1/CIP1)
por: Neise, D, et al.
Publicado: (2013) -
RSK Isoforms in Acute Myeloid Leukemia
por: Youn, Minyoung, et al.
Publicado: (2021)